Minocycline and Other Tetracycline Derivatives: A Neuroprotective Strategy in Parkinson's Disease and Huntington's Disease

This publication has 54 references indexed in Scilit:

• Minocycline markedly protects the neonatal brain against hypoxic‐ischemic injury
  Annals of Neurology, 2002
• Protective Effect of a Prosaposin-Derived, 18-Mer Peptide on Slowly Progressive Neuronal Degeneration after Brief Ischemia
  Journal of Cerebral Blood Flow & Metabolism, 2001
• Tetracycline derivatives and ceftriaxone, a cephalosporin antibiotic, protect neurons against apoptosis induced by ionizing radiation
  Journal of Neurochemistry, 2001
• Minocycline-induced lupus-like syndrome
  International Journal of Dermatology, 2001
• Minocycline Reduces Traumatic Brain Injury-mediated Caspase-1 Activation, Tissue Damage, and Neurological Dysfunction
  Neurosurgery, 2001
• Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release
  Human Molecular Genetics, 2001
• Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from Parkinsonian brain
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2000
• Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain
  Science, 1997
• Safety of long-term high-dose minocycline in the treatment of acne
  British Journal of Dermatology, 1996
• Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients
  Neuroscience Letters, 1994